Celtaxsys - Articles and news items

Celtaxsys gains US clearance for Phase 2 trial of acebilustat in patients with cystic fibrosis

Industry news / 7 July 2015 /

Celtaxsys has gained clearance from the US FDA to begin a Phase 2 clinical trial of acebilustat in adult patients with cystic fibrosis (CF) in the US…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+